Ani Pharmaceuticals Inc (ANIP) insider trading.
In Q3 2026, insiders at Ani Pharmaceuticals Inc reported 14 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $2.1M.
- Transactions
- 14
- Purchases (P)
- 0
- Sales (S)
- 11
- Net shares, P minus S
- -28,325
- Insiders
- 6
- Last filed
- 2026-09-30
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Carey Stephen P. | Officer · SVP & CFO | 5 | 0 | 4 |
| Cook Meredith | Officer · SR. VP, GENERAL COUNSEL & SEC. | 4 | 0 | 3 |
| Lalwani Nikhil | Director, Officer · PRESIDENT & CEO | 2 | 0 | 2 |
| Thoma Jeanne | Director | 1 | 0 | 1 |
| Gosebruch Henry O | Director | 1 | 0 | 0 |
| Gutwerg Ori | Officer · SVP, GENERICS | 1 | 0 | 1 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-29 | Carey Stephen P. | S (D) | 2,850 | $73 | 168,993 | Form 4 |
| 2026-09-15 | Lalwani Nikhil | S (D) | 5,400 | $71 | 339,089 | Form 4 |
| 2026-09-14 | Cook Meredith | S (D) | 500 | $70.79 | 73,924 | Form 4 |
| 2026-09-11 | Thoma Jeanne | S (D) | 1,000 | $71.53 | 26,762 | Form 4 |
| 2026-08-31 | Carey Stephen P. | S (D) | 2,850 | $72.8 | 171,843 | Form 4 |
| 2026-08-25 | Lalwani Nikhil | S (D) | 5,400 | $74.3 | 344,489 | Form 4 |
| 2026-08-19 | Gosebruch Henry O | A (A) | 6,662 | $0 | 6,662 | Form 4 |
| 2026-08-13 | Cook Meredith | S (D) | 500 | $75.48 | 74,424 | Form 4 |
| 2026-08-10 | Gutwerg Ori | S (D) | 3,162 | $77 | 75,534 | Form 4 |
| 2026-07-29 | Carey Stephen P. | S (D) | 2,850 | $81.36 | 174,693 | Form 4 |
| 2026-07-18 | Cook Meredith | F (D) | 2,466 | $79.2 | 74,924 | Form 4 |
| 2026-07-13 | Cook Meredith | S (D) | 500 | $81.84 | 77,390 | Form 4 |
| 2026-07-02 | Carey Stephen P. | M (A) | 3,313 | $49.51 | 180,856 | Form 4 |
| 2026-07-02 | Carey Stephen P. | S (D) | 3,313 | $86 | 177,543 | Form 4 |
Transaction codes in this quarter
Get ANIP insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=1023024&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · ANIP company page · Ani Pharmaceuticals Inc on SEC.gov
Questions
Are insiders buying or selling Ani Pharmaceuticals Inc (ANIP)?
In Q3 2026, insiders at Ani Pharmaceuticals Inc reported 14 non-derivative transactions on 14 Forms 3, 4 and 5: 0 open-market purchases and 11 sales worth $2.1M. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Ani Pharmaceuticals Inc insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/anip.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.